Search Results - Christopher F Bell

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Real-World Clinical Outcomes in Belimumab-Treated US African American and Hispanic Patients with Systemic Lupus Erythematosus: A Retrospective, Observational Study by Christopher F. Bell, Jake Chung, Bernard Rubin

    Published in Rheumatology and Therapy (2023-01-01)
    Get full text
    Article


  2. 2

    Correction: Real-World Clinical Outcomes in Belimumab-Treated US African American and Hispanic Patients with Systemic Lupus Erythematosus: A Retrospective, Observational Study by Christopher F. Bell, Jake Chung, Bernard Rubin

    Published in Rheumatology and Therapy (2023-11-01)
    Get full text
    Article


  3. 3

    Within-trial economic analysis of flare data from the BLISS-SC trial of subcutaneous belimumab in systemic lupus erythematosus by Christopher F Bell, Tasneem Lokhandwala, Binglin Yue, Anna D Coutinho

    Published in Lupus Science and Medicine (2021-04-01)
    Get full text
    Article


  4. 4

    Clinical and Economic Burden of Systemic Lupus Erythematosus in the Years Preceding End-Stage Kidney Disease Diagnosis: A Retrospective Observational Study by Shirley P. Huang, Amy Guisinger, Carlyne Averell, Christopher F. Bell, Bernie Rubin

    Published in Rheumatology and Therapy (2023-02-01)
    Get full text
    Article


  5. 5

    Evaluating the Use of Glucocorticoids Among Belimumab‐Treated Patients With Systemic Lupus Erythematosus in Real‐World Settings Using the Rheumatology Informatics System for Effect... by Nevin Hammam, Michael Evans, Christopher F. Bell, Kerry Gairy, Jinoos Yazdany, Gabriela Schmajuk

    Published in ACR Open Rheumatology (2022-10-01)
    Get full text
    Article


  6. 6

    Observational vignette study to examine patient and healthcare provider perceived impact of asthma-related exacerbations in the US by Phaedra T. Johnson, Christopher F. Bell, John White, Breanna Essoi, Linda Nelsen, Carlyne M. Averell

    Published in Multidisciplinary Respiratory Medicine (2019-11-01)
    Get full text
    Article


  7. 7

    Healthcare resource utilization and costs in patients with a newly confirmed diagnosis of lupus nephritis in the United States over a 5-year follow-up period by Christopher F. Bell, Benjamin Wu, Shirley P. Huang, Bernard Rubin, Carlyne M. Averell, Benjamin Chastek, Erin M. Hulbert

    Published in BMC Health Services Research (2024-05-01)
    Get full text
    Article


  8. 8

    Hemoglobin stability impact on healthcare resource utilization and costs among dialysis-dependent patients with anemia of end-stage kidney disease by Anna D. Coutinho, Malena Mahendran, Maral DerSarkissian, Sophie A. Kitchen, Christopher F. Bell, Mary Muoneke, Anna Richards

    Published in BMC Nephrology (2025-08-01)
    Get full text
    Article


  9. 9

    Evaluating the real-world effectiveness of belimumab in patients with SLE using SLE-related laboratory values and rheumatoid arthritis-derived disease activity measures: RAPID3, sw... by Christopher F Bell, Karen Worley, Bernard Rubin, Guillaume Germain, Sean D MacKnight, François Laliberté, Ana Urosevic, Mei Sheng Duh, Andrew Concoff

    Published in Lupus Science and Medicine (2024-05-01)
    Get full text
    Article


  10. 10

    Clinical and Economic Burden in Patients With Systemic Lupus Erythematosus During the First Year After Initiating Oral Corticosteroids: A Retrospective US Database Study by Maral DerSarkissian, Yuqian M. Gu, Mei Sheng Duh, John Benson, Shirley P. Huang, Carlyne Averell, Jensen Vu, Min‐Jung Wang, Christopher F. Bell

    Published in ACR Open Rheumatology (2023-06-01)
    Get full text
    Article


  11. 11

    Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19 During SARS-CoV-2 Delta and Omicron Waves in the USA by Mindy M. Cheng, Carolina Reyes, Sacha Satram, Helen Birch, Daniel C. Gibbons, Myriam Drysdale, Christopher F. Bell, Anvar Suyundikov, Xiao Ding, M. Cyrus Maher, Wendy Yeh, Amalio Telenti, Lawrence Corey

    Published in Infectious Diseases and Therapy (2023-01-01)
    Get full text
    Article


  12. 12

    A 5-Year Retrospective, Observational Study Assessing Rheumatoid Arthritis Disease Outcome Measures to Characterize Systemic Lupus Erythematosus Burden in the USA by Christopher F. Bell, Shirley P. Huang, Louise H. Yu, Maral DerSarkissian, Guillaume Germain, Andrew L. Concoff, Carlyne M. Averell, Bernard Rubin, Yuqian M. Gu, Mei Sheng Duh, Daniel J. Wallace

    Published in Rheumatology and Therapy (2022-12-01)
    Get full text
    Article


  13. 13

    Real-world effectiveness of sotrovimab in preventing hospitalization and mortality in high-risk patients with COVID-19 in the United States: A cohort study from the Mayo Clinic ele... by Christopher F Bell, Daniel C Gibbons, Myriam Drysdale, Helen J Birch, Emily J Lloyd, Vishal Patel, Corinne Carpenter, Katherine Carlson, Ediz S Calay, Arjun Puranik, Tyler E Wagner, John C O'Horo, Raymund R Razonable

    Published in PLoS ONE (2024-01-01)
    Get full text
    Article


  14. 14

    Real-world effectiveness of sotrovimab in preventing hospitalization and mortality in high-risk patients with COVID-19 in the United States: A cohort study from the Mayo Clinic ele... by Christopher F. Bell, Daniel C. Gibbons, Myriam Drysdale, Helen J. Birch, Emily J. Lloyd, Vishal Patel, Corinne Carpenter, Katherine Carlson, Ediz S. Calay, Arjun Puranik, Tyler E. Wagner, John C. O’Horo, Raymund R. Razonable

    Published in PLoS ONE (2024-01-01)
    Get full text
    Article


Search Tools: